All measles articles
-
NewsFirm advances measles antibodies toward clinical development
Researchers have identified two potent human monoclonal antibodies that could become the first antibody-based therapy for measles. The antibodies strongly neutralized the virus in laboratory studies and animal models, offering a potential new option for vulnerable people who cannot safely receive or fully benefit from vaccination.
-
NewsAbout 1 in 3 Americans say RFK Jr. recommends measles vaccination
The number of measles cases in the United States is at the highest level in decades, attributed to a decrease in vaccination against measles. The public remains evenly divided on whether or not U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recommends the MMR vaccine.
-
NewsEpidemiologist discusses Pennsylvania’s first measles deaths in 35 years
Epidemiologist Jennifer Horney highlights the importance of vaccinations after the deaths of two Pennsylvania residents – the first measles deaths in the state in 35 years.
-
NewsU.S. disease tracker launches to strengthen monitoring of vaccine-preventable diseases
A new website will track the spread of vaccine-preventable diseases across the United States to offer the public, the media, healthcare providers, public health officials, and policymakers reliable and visual information about current disease trends.
-
NewsNew Mexico measles outbreak estimated to cost $5.4 million
A cost analysis of the 2025 measles outbreak in New Mexico found that the outbreak carried an estimated societal cost of $5.4 million, or more than $53,000 per case.
-
NewsScripps Research scientists awarded $2M to advance global disease surveillance
Two Gates Foundation grants will expand wastewater surveillance and AI-driven disease monitoring to support faster public health responses worldwide.
-
NewsT cells may be key to stopping measles virus—and its deadly relatives
Scientists have discovered how T cells target paramyxoviruses, a viral family that includes measles virus and Nipah virus. Instead of vaccinating against one virus at a time, the researchers found that activating “cross-reactive” T cells may protect against the wider paramyxovirus family.
-
NewsScientists take crucial step in developing world’s first measles treatment
Scientists have characterized human antibodies capable of neutralizing measles virus. These antibodies bind to key sites on measles virus and prevent the virus from entering host cells.
-
NewsWhere people get their news influences their beliefs about vaccines
People who follow “new right” media outlets are more than twice as likely to be vaccine-hesitant compared to those who never engage with those outlets, a new study finds. Hesitant adults were more likely to rely on non-authoritative sources for health information.
-
NewsNew study examines measles vaccination coverage after a postelimination outbreak
In 2022–2023, a large postelimination measles outbreak occurred in central Ohio. A study found that 20 months after the outbreak, MMR coverage across the entire primary care network (PCN) population remained well below herd immunity levels, with minimal gains.
-
OpinionReversing the threat: How to stop measles from spreading again
As the Global Virus Network issues a stark warning over the significant resurgence of measles in the US and globally, William J. Moss, Sten H. Vermund, and Maggie L. Bartlett set out what needs to be done if the preventable harms of the current surge are to be reversed.
-
NewsRising measles cases highlight gaps in vaccination coverage and public health system vulnerabilities
The Global Virus Network (GVN) is closely monitoring a significant resurgence of measles in the United States and globally, reflecting a growing vulnerability in public health systems.
-
NewsVanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
-
NewsHealth experts from a new Commission call for a step change in vaccine access as coverage falls and potentially preventable outbreaks return
A group of leading UK health experts have today announced that they will be launching the Commission on Access to Vaccines to understand why access levels are falling across the UK and to recommend practical measures to reform vaccine delivery across the health system.
-
NewsUS study finds declining perception of safety of COVID-19, flu, and MMR vaccines
A sizable majority of Americans think the three vaccines that combat potentially deadly illnesses flu, Covid-19 and measles are safe to take, although perceptions of the safety of all three vaccines showed a statistically significant drop over the past three years.
-
NewsCommunity spread drives ongoing measles transmission in Europe
Preliminary data for 2025 show a significant drop in the number of reported measles cases across EU/EEA countries compared with 2024. However, these figures are still twice as high than those reported in 2023.
-
CareersThe National Collection of Pathogenic Viruses (NCPV): a critical resource for virology and public health
It’s now 25 years since the National Collection of Pathogenic Viruses (NCPV) was founded as a dedicated, secure, and relevant national virus repository for the UK. Jane Burton, Teresa Ramalho and Tilly Maybery explore how the collection has evolved - and is tackling future global health concerns.
-
NewsGlobal Virus Network warns of measles resurgence
The Global Virus Network (GVN) has expressed deep concern regarding the ongoing resurgence of measles in the United States and around the globe. Measles is one of the most contagious viral diseases known and can be lethal, particularly in unvaccinated children.
-
NewsAs US measles cases rise, views of MMR vaccine safety and effectiveness – and willingness to recommend it – drop
As U.S. measles cases rise, a new nationally representative panel survey finds a small but significant drop in the proportion of the public that would recommend that someone in their household get the MMR vaccine, which protects against measles, mumps, and rubella.
-
NewsPathogens are the biggest threats at festivals and mass gatherings
A comprehensive review led by public health experts reveals that infectious disease outbreaks and foodborne illnesses are the most common public health threats at youth-focused mass gatherings, ranging from music festivals and cultural celebrations to sporting and religious gatherings.